NO980276L - Fremgangsmåte for karakterisering av glykosyleringen av glykoproteiner og for in vitro bestemmelse av biotilgjengeligheten av glykoproteiner - Google Patents

Fremgangsmåte for karakterisering av glykosyleringen av glykoproteiner og for in vitro bestemmelse av biotilgjengeligheten av glykoproteiner

Info

Publication number
NO980276L
NO980276L NO980276A NO980276A NO980276L NO 980276 L NO980276 L NO 980276L NO 980276 A NO980276 A NO 980276A NO 980276 A NO980276 A NO 980276A NO 980276 L NO980276 L NO 980276L
Authority
NO
Norway
Prior art keywords
glycoproteins
glycosylation
bioavailability
characterizing
pct
Prior art date
Application number
NO980276A
Other languages
English (en)
Other versions
NO980276D0 (no
Inventor
Peter Hermentin
Reinhild Witzel
Original Assignee
Behring Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behring Diagnostics Gmbh filed Critical Behring Diagnostics Gmbh
Publication of NO980276D0 publication Critical patent/NO980276D0/no
Publication of NO980276L publication Critical patent/NO980276L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Det er beskrevet en fremgangsmåte for karakterisering av glykosyleringen av glyko- proteiner og en in vitro fremgangsmåte for bestemmelse av biotilgjengeligheten av glykoproteiner basert på hypotetisk ladningstall Z og som kan anvendes for både endogene og eksogene glykoproteiner.
NO980276A 1995-07-26 1998-01-21 Fremgangsmåte for karakterisering av glykosyleringen av glykoproteiner og for in vitro bestemmelse av biotilgjengeligheten av glykoproteiner NO980276L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19527054A DE19527054A1 (de) 1995-07-26 1995-07-26 Verfahren zur Charakterisierung der Glycosylierung von Glycoproteinen sowie zur in-vitro Bestimmung der Bioverfügbarkeit von Glycoproteinen
PCT/EP1996/002319 WO1997005490A1 (de) 1995-07-26 1996-05-30 Verfahren zur charakterisierung der glycosylierung von glycoproteinen sowie zur in-vitro bestimmung der bioverfügbarkeit von glycoproteinen

Publications (2)

Publication Number Publication Date
NO980276D0 NO980276D0 (no) 1998-01-21
NO980276L true NO980276L (no) 1998-01-21

Family

ID=7767674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980276A NO980276L (no) 1995-07-26 1998-01-21 Fremgangsmåte for karakterisering av glykosyleringen av glykoproteiner og for in vitro bestemmelse av biotilgjengeligheten av glykoproteiner

Country Status (13)

Country Link
US (1) US6096555A (no)
EP (1) EP0843821B1 (no)
JP (1) JP3631495B2 (no)
KR (1) KR19990035943A (no)
AT (1) ATE206524T1 (no)
AU (1) AU6003296A (no)
CA (1) CA2227743C (no)
DE (2) DE19527054A1 (no)
DK (1) DK0843821T3 (no)
ES (1) ES2162652T3 (no)
NO (1) NO980276L (no)
PT (1) PT843821E (no)
WO (1) WO1997005490A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020144310A1 (en) * 2000-01-28 2002-10-03 Lightfoot David A. Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same
US20030096281A1 (en) * 2001-09-14 2003-05-22 Ganesh Venkataraman Methods of making glycomolecules with enhanced activities and uses thereof
KR100982922B1 (ko) * 2002-01-17 2010-09-20 론자 바이올로직스 피엘씨 단백질을 생산할 수 있으며 무글루타민 배지에서 성장할 수있는 글루타민-요구성 인간세포
EP1587408A4 (en) * 2002-12-20 2007-09-05 Momenta Pharmaceuticals Inc GLYCAN MARKER FOR DIAGNOSIS AND MONITORING OF DISEASES
JP4077339B2 (ja) * 2003-03-06 2008-04-16 独立行政法人科学技術振興機構 高等植物の糖リン酸の網羅的分析法
DE102005050580A1 (de) * 2005-10-21 2007-04-26 Siegfried Biologics Gmbh Verfahren zur Charakterisierung der Qualität von Sialoglycoproteinen über eine Isoformenzahl I und dessen Verwendung
EP2358731B1 (en) * 2008-12-19 2016-03-09 Momenta Pharmaceuticals, Inc. Methods related to modified glycans
AU2011237442A1 (en) 2010-04-07 2012-10-18 Momenta Pharmaceuticals, Inc. High mannose glycans
US9170249B2 (en) 2011-03-12 2015-10-27 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing N-glycans in glycoprotein products
US20160145589A1 (en) 2011-06-24 2016-05-26 Green Cross Corporation Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
WO2013181575A2 (en) 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to denosumab
KR101380740B1 (ko) * 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 이듀로네이트-2-설파타제의 정제
US9150841B2 (en) 2012-06-29 2015-10-06 Shire Human Genetic Therapies, Inc. Cells for producing recombinant iduronate-2-sulfatase
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
WO2014186310A1 (en) 2013-05-13 2014-11-20 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins

Also Published As

Publication number Publication date
DE59607840D1 (de) 2001-11-08
DK0843821T3 (da) 2002-01-28
ES2162652T3 (es) 2002-01-01
NO980276D0 (no) 1998-01-21
PT843821E (pt) 2002-03-28
KR19990035943A (ko) 1999-05-25
JP2000503109A (ja) 2000-03-14
CA2227743A1 (en) 1997-02-13
AU6003296A (en) 1997-02-26
CA2227743C (en) 2008-01-29
EP0843821A1 (de) 1998-05-27
US6096555A (en) 2000-08-01
EP0843821B1 (de) 2001-10-04
WO1997005490A1 (de) 1997-02-13
MX9800690A (es) 1998-09-30
ATE206524T1 (de) 2001-10-15
JP3631495B2 (ja) 2005-03-23
DE19527054A1 (de) 1997-01-30

Similar Documents

Publication Publication Date Title
NO980276D0 (no) Fremgangsmåte for karakterisering av glykosyleringen av glykoproteiner og for in vitro bestemmelse av biotilgjengeligheten av glykoproteiner
DE69636854D1 (de) Zugriffs- und lieferungssystem für on-line/informationsdienste
TR199600357A2 (tr) Rekombinant simanlik (Ob) proteinleri.
NL1000352C2 (nl) Elektronisch betaalsysteem met verschillende rekeneenheden, elektronisch betaalmiddel alsmede werkwijze voor elektronisch betalen.
AU4837999A (en) System and method of assessing the quality of an identification transaction using an identification quality score
AU5448696A (en) Method and apparatus for routing confidential information
AU5355196A (en) Identifying application capabilities for teleconference connections
AU7304798A (en) Voice recognition for information system access and transaction process ing
AU6058696A (en) Method and system for providing secure EDI over an open network
AU4902096A (en) System and method for providing end-user free email
DE69625990D1 (de) Verarbeitungssystem für Musikinformation
TR199701017T1 (xx) 2-metil-tieno-benzodiazepinin kristal bi�imi ve i�lem.
AU7819198A (en) System and method for sorting program guide information
ATE431159T1 (de) Für rsv f-proteine spezifische, menschliche, monoklonale antikörper mit hoher affinität
DE69621831T2 (de) Piperazinderivative als tachykinin antagonisten
HU9601866D0 (en) An optical telecommunication system, method and amplifier
AU3498697A (en) System and method for developing and processing automatic response unit (aru) services
ATE252158T1 (de) Nicht-nukleotid verknüpfende reagentien
AU8918398A (en) System and method for communicating transaction capabilities application part information
AU2057895A (en) System and method for inspecting lenses
IL122606A (en) (S)-hydroxa-nitrile-lyase
GB2307041B (en) Sheets,kits and methods for detecting antigens or antibodies
AU1275397A (en) System and method for telephony service card processing
IT1282848B1 (it) Vetro laminato o stratificato e metodo per la sua fabbricazione.
NZ334744A (en) Method for determining expression of aberrant forms of APC protein

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application